TACC3 and lung adenocarcinoma: Furthermore, pancancer survival analysis suggested that elevated TACC3 expression predicted poorer OS and RFS in multiple cancers, including pancreatic ductal adenocarcinoma and lung adenocarcinoma (Supplementary Fig. 1f, g).